Back to Search
DEBORA WILLIAMS-HERMAN, M.D.
M.D.
Pediatric Allergy/Immunology Physician
NPI: 1194106245Individual
Specialties, Licenses & Credentials
Pediatrics — Pediatric Allergy/Immunology
Code: 2080P0201X
G68413(CA)
Research & Publications (8)
Efficacy and safety of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes: a 54-week study.
PMID 19232032·Curr Med Res Opin·2009
4-observational
Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis.
PMID 18954434·BMC Endocr Disord·2008
8-other
Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency.
PMID 18518892·Diabetes Obes Metab·2008
4-observational
Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on beta-cell function in patients with type 2 diabetes: a model-based approach.
PMID 18476982·Diabetes Obes Metab·2008
1-meta
Placebo-controlled study of montelukast and budesonide on short-term growth in prepubertal asthmatic children.
PMID 17659605·Pediatr Pulmonol·2007
2-rct
Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes.
PMID 17485570·Diabetes Care·2007
2-rct
Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes.
PMID 17130196·Diabetes Care·2006
2-rct
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus.
PMID 17001471·Diabetologia·2006
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1020 1ST AVE, C/O CSL BEHRING INC.
KING OF PRUSSIA, PA 19406 - Phone
- (610) 308-0173
Quick Facts
- NPI
- 1194106245
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 8
Are you this provider?
Claim Your Profile